Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome 26S subunit ATPase 5 (PSMC5), also known as 26S proteasome regulatory subunit 8 or SUG1, is an ATPase component of the 19S regulatory particle of the 26S proteasome complex. The 26S proteasome is essential for ubiquitin-dependent protein degradation in eukaryotic cells. PSMC5, a member of the AAA+ ATPase family, is involved in unfolding and translocation of ubiquitinated proteins into the 20S core particle for degradation. It plays key roles in cellular protein quality control, cell cycle regulation, apoptosis, antigen processing for immune presentation, and regulation of transcription through interactions with transcription factors and nuclear receptors. Dysfunction of the proteasome system, including defects in PSMC5, has been implicated in cancer, neurodegenerative diseases, and rare genetic syndromes. While broadly targeted by proteasome inhibitors in cancer therapy, PSMC5 itself has not yet been selectively targeted by small molecules.
Proteasome inhibitors bind to and inhibit proteolytic activity, preventing degradation of ubiquitinated proteins, leading to apoptosis especially in rapidly dividing cells
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit ATPase 5 (PSMC5).